TEVA 2083 (Hydrochlorothiazide 25 mg)

Pill imprint TEVA 2083 has been identified as Hydrochlorothiazide 25 mg.

Hydrochlorothiazide is used in the treatment of high blood pressure; edema; diabetes insipidus; nephrocalcinosis; osteoporosis and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy. Hydrochlorothiazide 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for TEVA 2083

Hydrochlorothiazide 25 mg TEVA 2083
Hydrochlorothiazide 25 mg TEVA 2083
Hydrochlorothiazide 25 mg TEVA 2083
Hydrochlorothiazide
Imprint:
TEVA
2083
Strength:
25 mg
Color:
Orange
Shape:
Round
Availability:
Prescription only
Drug Class:
Thiazide diuretics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00172-2083

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)